HCV-IN-31 (compound 4) is a HCV inhibitor, with an EC50/EC95 of 15.7 μM for HCV replicon[1].
[1]. Jean-Pierre Sommadossi, et al. BETA-D-2-DEOXY-2-ALPHA-FLUORO-2- BETA-C-SUBSTITUTED-2-MODIFIED N6-SUBSTITUTED PURINE NUCLEOTDES FORHCV TREATMENT. US20160257706A1.
















